Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alkermes advanced after analyst upgrades shares on expected Risperdal Consta strength
Alkermes advanced after analyst upgrades shares on expected Risperdal Consta strength
Alkermes advanced after analyst upgrades shares on expected Risperdal Consta strength
Submitted by
admin
on December 19, 2008 - 10:26am
Source:
Yahoo/AP
News Tags:
Alkermes
Risperdal
JNJ
Eli Lilly
Headline:
Alkermes advanced after analyst upgrades shares on expected Risperdal Consta strength
Do Not Allow Advertisers to Use My Personal information
